TC Biopharm (Holdings) Plc (TCBP)

NASDAQ: TCBP · IEX Real-Time Price · USD

1.555

-0.015 (-0.96%)

Apr 26, 2024, 3:00 PM EDT - Market open

TC Biopharm (Holdings) Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	0	3.84	1.98	1.98	3.43
Revenue Growth (YoY)	-	94.30%	0%	-42.26%	-
Gross Profit	0	3.84	1.98	1.98	3.43
Selling, General & Admin	6.47	8.34	3.11	2.21	3.01
Research & Development	7.77	7.59	6.16	6.68	8.61
Other Operating Expenses	0	0	-0.01	-0.57	-1.56
Operating Expenses	14.24	15.93	9.26	8.32	10.07
Operating Income	-14.24	-12.08	-7.28	-6.34	-6.64
Interest Expense / Income	0.08	6.75	3.44	0.29	0.28
Other Expense / Income	-7.33	-15.8	4.26	-0	-0.02
Pretax Income	-7	-3.03	-14.98	-6.63	-6.89
Income Tax	-1.09	-1.72	-1.41	-1.17	-0.83
Net Income	-5.91	-1.31	-13.58	-5.46	-6.07
Shares Outstanding (Basic)	6	1	1	1	-
Shares Outstanding (Diluted)	6	1	-	-	-
Shares Change	799.07%	24.02%	-	-	-
EPS (Basic)	-19.20	-38.20	-695.20	-288.40	-340.00
EPS (Diluted)	-19.20	-38.20	-695.20	-288.40	-340.00
Free Cash Flow	-10.66	-15.48	-6.53	-4.42	-8.67
Free Cash Flow Per Share	-34.49	-450.47	-235.53	-159.36	-
Gross Margin	-	100.00%	100.00%	100.00%	100.00%
Operating Margin	-	-314.32%	-367.96%	-320.36%	-193.78%
Profit Margin	-	-34.17%	-686.12%	-275.84%	-177.07%
Free Cash Flow Margin	-	-402.60%	-329.79%	-223.14%	-252.96%
EBITDA	-6.28	4.49	-10.52	-5.26	-5.71
EBITDA Margin	-	116.77%	-531.67%	-265.97%	-166.75%
Depreciation & Amortization	0.63	0.77	1.03	1.08	0.9
EBIT	-6.91	3.72	-11.54	-6.34	-6.62
EBIT Margin	-	96.75%	-583.47%	-320.31%	-193.14%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).